“…Previously, we reported that the HO-1 pathway is a key mechanism for both the adaptation of cells to stressful conditions and their recovery from injurious events in human pulp and PDL cells [27][28][29][30][31][32]. Moreover, HO-1 has therapeutic potential in hepatoprotection [33], inflammatory arthritis [34], psoriasiform skin lesions [35], neuroinflammation [36], inflammatory bowel disease [37], and periodontitis [15]. In our previous study [15], the inhibition of HO-1 in LPS-and nicotine-stimulated human PDL cells resulted in the suppression of iNOS and COX-2 expression, as well as a reduction in NO and PGE 2 levels.…”